Long-term effects of progestins on bone quality and fractures
- 1 January 2007
- journal article
- review article
- Published by Informa UK Limited in Gynecological Endocrinology
- Vol. 23 (sup1), 45-52
- https://doi.org/10.1080/09513590701584931
Abstract
The effects of progestins on the quality of bone and their influence on the risk of fractures are reviewed. Data discussed are based on experimental studies in vivo that generally lasted for longer than one year. Information is given on the background of osteoporosis and on several means of inducing changes in bone quality. In young women who start using oral contraceptives based on progestins alone shortly after pubertal development, a significant decrease in bone quality has been documented. World Health Organization experts have concluded that this is not a real argument for restrictions on the use of these contraceptives. In postmenopausal women, no evidence has been found for a bone-protective or an estrogen-antagonistic effect of progestins. A wide range of estrogens have been used that have shown positive effects on bone, which are not antagonized by progestins. The therapeutic use of high-dose megestrol acetate may result in marked negative effects on bone, leading to severe osteoporosis, possibly due to the inherent glucocorticoid activity of this progestin. Other pharmacotherapeutic agents that can be used in postmenopausal therapy, and that clearly have beneficial effects on bone, are discussed.Keywords
This publication has 59 references indexed in Scilit:
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 μg) in women with postmenopausal symptoms: Updated analysis of three randomized, controlled trialsClinical Therapeutics, 2006
- Calcium plus Vitamin D Supplementation and the Risk of FracturesNew England Journal of Medicine, 2006
- Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal womenFertility and Sterility, 2005
- Non‐pharmacological means to prevent fractures among older adultsAnnals of Medicine, 2005
- Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment periodClimacteric, 2005
- The effects of progestins on bone density and bone metabolism in postmenopausal women: A randomized controlled trialAmerican Journal of Obstetrics and Gynecology, 2005
- Effects of drospirenone/estrogen combinations on bone metabolismClimacteric, 2005
- Osteoporosis Associated With Megestrol AcetateMayo Clinic Proceedings, 2004
- Contraceptive use in teens: A threat to bone health?Journal of Adolescent Health, 2004